Interview with Jenny Devenport

This is a series of episodes and today's content is the first episode. Join Jenny and I while we dive into her career and discuss important points about the following:

  • What is Launch and Lifecycle
  • How as it evolved in the last 2 decades with respect to
    • Phase IV studies
    • Observational studies
    • RWE
    • HTA
    • Global vs local positions
  • What is the relationship between HTA vs non-HTA areas and collaboration with stakeholders
  • Collaboration with the regulatory side
  • Involvement in strategic evidence generation
  • Number of statisticians/programmers supporting this area
  • Organization within or outside of statistics departments 
  • Outsourcing approaches (strategic parts, RWE and outcomes research, studies, NMA/health economics)

Listen to this episode and share this with your friends and colleagues!

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry. Innehållet i podden är skapat av Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry och inte av, eller tillsammans med, Poddtoppen.

The Effective Statistician - in association with PSI

What is the current state of Launch and Lifecycle work and how did it evolve?

00:00